Loading...
LifeStance Q1 2025 Earnings Report
Estimated Revenue:$336M
+10.5% YoY
Estimated EPS:$0.01
+110.8% YoY
Key Takeaways
LifeStance Health Group, Inc. announced strong first quarter 2025 results, with revenue increasing 11% to $333.0 million and achieving a net income of $0.7 million, a significant improvement from a net loss in the prior year. The company also saw a 10% increase in its clinician base and visit volumes, contributing to its financial performance.
Revenue increased 11% to $333.0 million compared to $300.4 million in Q1 2024.
Net income reached $0.7 million, a substantial improvement from a net loss of $21.1 million in the prior year.
The clinician base grew 10% to 7,535 clinicians, with visit volumes also increasing 10% to 2.1 million.
Adjusted EBITDA increased 25% to $34.6 million, or 10.4% of total revenue, driven by higher revenue per visit and lower center costs.
Forward Guidance
LifeStance reiterated its full-year 2025 guidance and provided outlook for the second quarter of 2025, expecting continued growth in revenue, Center Margin, and Adjusted EBITDA.
Positive Outlook
- Full year 2025 revenue is expected to be between $1.40 billion and $1.44 billion.
- Full year 2025 Center Margin is projected to be between $440 million and $464 million.
- Full year 2025 Adjusted EBITDA is anticipated to be between $130 million and $150 million.
- Second quarter 2025 total revenue is expected to be between $332 million and $352 million.
- Second quarter 2025 Adjusted EBITDA is projected to be between $28 million and $34 million.
Challenges Ahead
- The company did not provide a reconciliation for forward-looking Center Margin and Adjusted EBITDA guidance due to the inability to accurately estimate variables and individual adjustments without unreasonable effort.
- Potential risks include reduced reimbursement rates from third-party payors, which could harm the business.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...